Lung cancer laboratory tests: Difference between revisions
Jump to navigation
Jump to search
Mahshid |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Lung cancer}} | {{Lung cancer}} | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}} {{STA}} | ||
==Overview== | ==Overview== |
Revision as of 16:23, 13 February 2018
Lung cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Lung cancer laboratory tests On the Web |
American Roentgen Ray Society Images of Lung cancer laboratory tests |
Risk calculators and risk factors for Lung cancer laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Saarah T. Alkhairy M.D
Overview
The laboratory findings associated with lung cancer are the following: neutropenia, hyponatremia, hypokalemia, hypercalcemia, respiratory acidosis, hypercarbia, hypoxia, and tumor cells in sputum and pleural effusion cytology.
Tests
- CBC
- Neutropenia in patients with a recent history of chemotherapy
- Serum electrolytes
- Hyponatremia from Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
- Hypokalemia from Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
- Hypercalcemia with normal PTH levels from squamous cell carcinoma (from secretion of parathyroid hormone-related peptide (PTH-rP))
- ABG
- Respiratory acidosis from respiratory failure
- Hypercarbia from respiratory failure
- Hypoxia from respiratory failure
- Sputum cytology
- Sputum cytology demonstrates tumor cells
- Needle thoracentesis
- Pleural effusion cytology demonstrates tumor cells